Figure 2.
Comparison of the cumulative incidence of neoplastic progression in terms of MPD dilatation (≥2.5 mm) and the presence of pancreatic cysts (≥5 mm) at initial surveillance. The incidence at 5 years was 6.4% in patients with MPD dilatation (≥2.5 mm) and cysts, 1.0% in patients with only MPD dilatation, and 0.8% in patients with only pancreatic cysts. MPD, main pancreatic duct.